Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 1,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Psoriatic Arthritis
Interventions: NDI-034858, Placebo; Drug · Other
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 23
States / cities: Palm Desert, California • Upland, California • Hollywood, Florida + 19 more

Conditions: Breast Cancer, Lymphoma, Chemotherapy Effect
Interventions: Arterial blood pressure, Vascular Ultrasound, Venous blood sample, Skin microcirculatory blood flow; Other
Lead sponsor: Carl Ade, M.S., Ph.D.; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Colorectal Cancer
Interventions: small media, group education (multicomponent); Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 50 Years and older
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Plantar Warts
Interventions: Nowarta110, Placebo; Drug
Lead sponsor: Nowarta Biopharma Inc; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Huntington Beach, California

Conditions: Kidney Failure, Acute
Interventions: Not listed
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 18 Years and older
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 10
States / cities: Denver, Colorado • Washington D.C., District of Columbia • Portland, Maine + 6 more

Conditions: Breastfeeding, SUID, SIDS
Interventions: Prenatal Safe Sleep Mobile Health (mHealth) Messaging, Prenatal Breastfeeding Mobile Health (mHealth) Messaging, Postnatal Safe Sleep Mobile Health (mHealth) Messaging, Postnatal Breastfeeding Mobile Health (mHealth) Messaging; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 14 Years and older · Female only
Enrollment: 2,093 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Social Media Treatments; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: Human Pancreatic Islets; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2033
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Otitis Media
Interventions: Tympanocentesis, Nasal Phalangeal Swab and Wash, Blood Draw; Procedure · Other
Lead sponsor: Rochester General Hospital; Other
Eligibility: 6 Months to 36 Months
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Dementia
Interventions: Dyadic Music-based Intervention (MBI), Reminiscence Activity; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cervical Cancers, HPV
Interventions: HPV testing; Diagnostic Test
Lead sponsor: University of Rochester; Other
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Surgical Wound
Interventions: Cardiva Mid-Bore Venous Vascular Closure Device (VVCS); Device
Lead sponsor: Cardiva Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Atlanta, Georgia • Ridgewood, New Jersey • Austin, Texas

Conditions: Nutrition, Healthy Diet, Food Preferences
Interventions: UPF Warning Labels, No Labels (Control); Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 13 Years to 29 Years
Enrollment: 1,012 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Breast Carcinoma, Colon Carcinoma, Kidney Carcinoma, Lymphoma, Non-Small Cell Lung Carcinoma, Prostate Carcinoma
Interventions: Internet-Based Intervention, Survey Administration; Other
Lead sponsor: University of Southern California; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Asthma
Interventions: DGA Diet, MCT Diet, KETO Diet; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Interventions: HDMP + rituximab as a means of debulking prior to initiating venetoclax.; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: Not listed
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Prader-Willi Syndrome
Interventions: CSTI-500; Drug
Lead sponsor: ConSynance Therapeutics; Industry
Eligibility: 13 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Mechanistic Self-Dehumanization Condition, Control Condition
Interventions: The Ten Item Personality Inventory, Mechanistic Self-Dehumanization Condition, Debrief, Control Condition, Clinical Interview, Self-Report Measures, Blood Draw; Other · Diagnostic Test
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Knee Injury
Interventions: Localized Knee Proprioception Training Program, Independent Home-Based Proprioception Training; Behavioral
Lead sponsor: Marshall University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Huntington, West Virginia

Conditions: Otitis Media, Otitis Media Chronic, Otitis Media Effusion, Otitis Media Recurrent, Otitis Media in Children
Interventions: CLiKX® Tympanostomy Tube Delivery System; Device
Lead sponsor: ClinQure, Inc.; Network
Eligibility: 6 Months and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Louisville, Kentucky • Houston, Texas • Mesquite, Texas + 1 more

Conditions: Dengue
Interventions: Cohort 1 - Group 1 JNJ High Dose, Cohort 1 - Group 2 JNJ Medium Dose, Cohort 1 - Group 2 JNJ Low Dose, Cohort 1 - Group 1/2 Placebo; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland • Burlington, Vermont

Conditions: Achondroplasia
Interventions: Recifercept; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 3 Months to 10 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 6
States / cities: Aliso Viejo, California • Irvine, California • Long Beach, California + 3 more

Conditions: Breast Cancer, Head and Neck Cancer, Squamous Cell Carcinoma, Lymphoma, Pancreatic Cancer, Liver Cancer, Colon Cancer, Lung Cancer, Bile Duct Cancer, Chordoma of Sacrum, Sarcoma
Interventions: INT230-6, anti-PD-1 antibody, anti-CTLA-4 antibody; Drug · Biological
Lead sponsor: Intensity Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 7
States / cities: Los Angeles, California • Newport Beach, California • Baltimore, Maryland + 4 more

Conditions: Influenza, COVID-19 (Coronavirus Disease 2019)
Interventions: Investigational Influenza Vaccine, Investigational COVID-19 Vaccine, Investigational Influenza and COVID-19 Combination Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Licensed Influenza Vaccine 3, Licensed COVID-19 Vaccine; Biological · Combination Product
Lead sponsor: BioNTech SE; Industry
Eligibility: 18 Years and older
Enrollment: 2,650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 31
States / cities: Anaheim, California • Lake Forest, California • Riverside, California + 26 more

Search by objective public record fields.

A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function

Promoting Colorectal Cancer Screening in Rural Colorado

A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury

Social Media and Risk Reduction Teaching-Enhanced Reach

Social Media Obesity Treatment for College Students

Islet Allotransplantation in Type 1 Diabetes

Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

Feasibility of a Dyadic Music-based Intervention for Persons Living With Dementia and Their Care Partners

Advancing Cervical Cancer Screening Through the Emergency Department - IIS

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

Effects of UPF Warning Labels on Social Media Among Teens and Young Adults

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Nutrition for Asthmatics

Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients

A Study of CSTI-500 in Patients With Prader-Willi Syndrome

Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Biofeedback Training Targeting at Knee Proprioception

CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes

An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People